Psilocybin

044: Interview with Dr. Rosalind Watts, Clinical Psychologist in the Psychedelic Research Group at Imperial College London by Joe

Rosalind Watts photo.jpg

This is Entheogen. Elevate the Conversation.

Please support Entheogen by making a donation on Patreon. Become a Patron for as little as $1. Pledge just $3 or more, and get early access to new episodes, plus exclusive Patron-only features. Head over to EntheogenShow.com and click on Support.

Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook. Thanks for listening.

It’s April 2, 2017, and we are talking with Dr. Rosalind Watts, Clinical Psychologist at Imperial College London, working alongside Dr. Robin Carhart-Harris.

  • Joe’s story of psilocybin on his first “date” with his now-wife, and psilocybin’s role in their engagement

  • The Couples Using Magic Mushrooms as Relationship Therapy

  • Kevin’s regular practice of taking psychedelic medicine with his wife

  • How Ros came to study psychedelic therapy after initially becoming disillusioned with the limits of talk therapy for the treatment of anxiety and depression; her initial skepticism about psychedelics based on their negative legacy

  • The importance of the patient-therapist relationship

  • Some guidelines from one of the father figures of psychedelic therapy, Bill Richards: “We prepare people to welcome whatever they may encounter – no picking and choosing. Sometimes you have to go through the dark night to get to the top of the mountain and the sunrise. If the inner dragon or monster appears, look him in the eye – go straight towards him. If you look the monster in the eye and go towards it, ask it what it wants – there’s always resolution, transformation, and new knowledge. When you run from it, you get into panic and paranoia, like a typical nightmare – and then you say, ‘I’ve had a bad trip.’”

  • Although psychedelics including psilocybin tend to be considered non-addictive, there are examples of people using them habitually

  • Ros mentions some examples of people in the psilocybin study for depression giving up addictions and habitual behavior

  • To help fund this important research, visit the Psychedelic Research Group at Imperial College London

040: Checking in with Kirk Rutter, Psilocybin Research Participant by Joe

This is Entheogen. Elevate the Conversation.

Please support Entheogen by making a donation on Patreon. Become a Patron for as little as $1. Pledge just $3 or more, and get early access to new episodes, plus exclusive Patron-only features. Head over to EntheogenShow.com and click on Support.

Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook. Thanks for listening.

It’s February 26, 2017, and we are checking in with Kirk Rutter, who joined us for Episode 025: Psychedelic Medicine Trials with Participant Kirk Rutter.

Topics:

  • Kirk’s Organizational Upgrade
  • Ganesh Chant/Mantra (108 times)
  • Barack Obama’s “Fired up, ready to go
  • The zoo
  • Ecological mindset
  • Vegetarianism
  • Hanlon's razor
  • Burning Man changed Brad’s life

037: Dr. Sarah Mennenga from NYU Experimental Therapeutics Laboratory on Using Psilocybin to Treat Anxiety and Depression in Cancer Patients by Joe

This is Entheogen. Talk about tools for generating the divine within.

Today is December 18, 2016, and we are discussing the recent publication of studies from NYU and Johns Hopkins showing that psilocybin can reduce anxiety and depression in cancer patients, and we’re pleased to be joined by Dr. Sarah Mennenga from the NYU Experimental Therapeutics Laboratory.

Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook. Thanks for listening.

Your pledges make the show possible! We're trying to cover expenses by asking our fans to pledge at Patreon.com/Entheogen. We really appreciate your support!

Topics:

  • We are grateful to be joined by Dr. Sarah Mennenga, Doctor of Neuroscience, NYU Experimental Therapeutics Laboratory

  • NYU and Johns Hopkins just released studies showing that psilocybin can reduce anxiety and depression in cancer patients

  • 80 percent of participants showed significant reduction of anxiety and depression

  • “One theory is that psilocybin interrupts the circuitry of self-absorbed thinking that is so pronounced in depressed people, making way for a mystical experience of selfless unity” i.e. interrupting or disrupting the Default Mode Network?

  • What is the neurological basis for the geometric shapes and auditory effects that characterize the psilocybin experience. What part does suggestibility play in the experience?

  • The “intensity of the mystical experience described by patients correlated with the degree to which their depression and anxiety decreased” – Why is that? What is it about the nature of the psychedelic or mystical experience that does this?

    • Octavian Mihai “saw black smoke rising from my body”

    • Kevin, a participant in the Johns Hopkins study saw “spirals of iridescent spheres that folded in on themselves”. “But you have to approach the session with the right intentions of why you’re doing it. Because you’re going to meet yourself.”

  • Study protocols, and the unique considerations for psychedelic session
    • “seven-hour music playlists.[...] N.Y.U. leaned toward New Age and world music — Brian Eno; sitars; didgeridoos. Johns Hopkins favored Western classical.”

    • Chalice

    • Buddha statue

  • Collaboration among the few institutions doing psychedelic research
  • Criticism from the academic/scientific community?
  • Political concerns; safety concerns around legalization

  • Stigma in the academic community?

  • fMRI scanning during a psychedelic experience?

  • NYU seeking participants in two upcoming studies:

  • NYU seeking $10 million funding for center to study psychedelics

How to Help:

Further Reading:

 

033: Interview with Rick Doblin, Alex Grey & Allyson Grey at Burning Man 2016 by Joe

Thank you so much for listening to Entheogen and for supporting us on Patreon and by telling your friends.

At Burning Man in 2014, we were inspired to create Entheogen (after a talk with Meriana Dinkova). Since then, we’ve released about one-and-a-half episodes per month.

On this, our two-year anniversary since posting the first episode, we are beyond overjoyed to share with you our very first “on location” recording, and the first time we’ve all recorded in person together –

Burning Man 2016.

We had the great pleasure and honor to speak with not one, not just two, but three pioneers and key drivers in the movement to mainstream psychedelic medicine:

Alex Grey & Allyson Grey, co-founders of CoSM, the Chapel of Sacred Mirrors (CoSM.org).

Rick Doblin, founder and executive director of MAPS, the Multidisciplinary Association for Psychedelic Studies (MAPS.org).

We thank deeply all three of our esteemed guests for their time and generosity of spirit.

We’d also like to thank Dr. Bronner’s ReFOAMation Village for their hospitality and Alex & Allyson for graciously hosting the recording in their RV.

Topics:

  • Alex & Allyson Grey’s take on the state of the movement to mainstream psychedelics

  • Has non-violence hamstrung our progress?

  • Alex & Allyson’s $2000 fine for cannabis possession upon entering Burning Man

  • Alex mentions Roland Griffiths’ reprisal of Walter Pahnke’s Good Friday Experiment at Johns Hopkins University: Hopkins Scientists Show Hallucinogen In Mushrooms Creates Universal “Mystical” Experience

  • Rick Doblin discusses the improved relationship with Law Enforcement and the Burning Man organization including better integration of the Zendo Project at Burning Man 2016

  • Rick quotes Einstein: “There’s no conflict between science and religion. There’s a conflict between bad science and bad religion.”

  • Rick talks about how he sees psychedelics being integrated into society in 25 years

  • Rick discusses the “beautiful breakup” he had while on MDA

  • Rick compares MDA to MDMA

  • Allyson discusses her personal experiences with MDA and MDMA

  • Alex, Allyson, and Rick discuss their milestones this year: 20 years since the founding of CoSM and 30 years since the founding of MAPS

  • Rick describes building a handball court at New College of Florida, overlooking the nudist colony where his girlfriend was lifeguarding

  • Rick discusses the first responders and veterans enrolled in the MDMA for PTSD study (“not just for hippies at Burning Man”)

  • Cannabis as a neuroprotective, anti-tumor agent (and it makes you feel better too)

  • Carl Sagan’s friendship with Lester Grinspoon

  • Carl Sagan’s secret use of cannabis for 40 years

  • Psychedelics and schizophrenia

  • Rick’s idea to create a “drug license” system

  • Time to “come out of the psychedelic closet”

  • MAPS organizes Global Psychedelic Dinners to encourage “coming out” about our psychedelic use

  • BuildEntheon.com

 

Update: this episode has been remastered since the original release.

029: Build Entheon with Alex and Allyson Grey by Joe

This is Entheogen. Talk about tools for generating the divine within.

Today is May 24 2016, and we are discussing Building Entheon with Alex and Allyson Grey.

Find the notes and links for this and other episodes at EntheogenShow.com. Sign up to receive an email when we release a new episode. Follow us @EntheogenShow on Twitter and like EntheogenShow on FaceBook. Thanks for listening.

Topics:

  • Entheon is a place to discover the divine within
  • Why build a psychedelic temple?
  • BuildEntheon.com – Almost to the stretch goal of $200K
  • Entheon is a 12,000 sq ft building, three floors including a gallery of international visionary art
  • Prehistoric artifacts document early cultures who made art and had a relationship with entheogens
  • “It’s important for our psychedelic sacramental culture to have evidence that in our generation there were people who valued love, unity, spirituality, and peace over commerce and war.” - Allyson Grey
  • LSD is derived from ergot fungus, which shares similar characteristics with psilocybin mushrooms.
  • Allyson recommends Robert Barnhart’s movie, A New Understanding: The Science of Psilocybin. (We have interviewed the producer and discussed the film on Entheogen.)
  • Visit BuildEntheon.com to support the campaign! Check out the amazing original works of art and other rewards.